LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

Kodu・Aktsiate loetelu・Pulse Biosciences Inc

Pulse Biosciences Inc

Avatud

SektorTervishoid

12.99 -4.2

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.9

Max

13.47

Põhinäitajad
By Trading Economics
Sissetulek	-217K -19M
Müük	86K 86K
Aktsiakasum	-0.29
Kasumimarginaal	-22,540.698
Töötajad	75
EBITDA	-228K -19M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+62% upside

Turustatistika
By TradingEconomics
Turukapital	-179M 958M
Eelmine avamishind	17.19
Eelmine sulgemishind	12.99

Uudiste sentiment

By Acuity

50%

177 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. nov 2025, 23:36 UTC

Kuumad aktsiad

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19. nov 2025, 22:13 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19. nov 2025, 21:55 UTC

Suurimad hinnamuutused turgudel

Amgen Lung Cancer Drug Gets Full Approval From FDA

19. nov 2025, 21:43 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19. nov 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19. nov 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19. nov 2025, 23:47 UTC

Tulu

Lenovo Group 2Q EPS $2.52 >0992.HK

19. nov 2025, 23:46 UTC

Tulu

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19. nov 2025, 23:45 UTC

Tulu

Lenovo Group 2Q Rev $20.5B >0992.HK

19. nov 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19. nov 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19. nov 2025, 23:40 UTC

Tulu

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19. nov 2025, 22:55 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19. nov 2025, 22:41 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19. nov 2025, 22:30 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19. nov 2025, 22:27 UTC

Omandamised, ülevõtmised, äriostud

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19. nov 2025, 22:08 UTC

Tulu

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19. nov 2025, 22:00 UTC

Tulu

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19. nov 2025, 21:58 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19. nov 2025, 21:52 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19. nov 2025, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. nov 2025, 21:49 UTC

Market Talk

Tulu

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19. nov 2025, 21:38 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19. nov 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B

19. nov 2025, 21:27 UTC

Omandamised, ülevõtmised, äriostud

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19. nov 2025, 21:24 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

62% tõus

12 kuu keskmine prognoos

Keskmine 22 USD 62%

Kõrge 22 USD

Madal 22 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

177 / 374 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.